John H Stone Selected Research

Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

10/2022	The effect of achieving serological remission on subsequent risk of relapse, end-stage renal disease and mortality in ANCA-associated vasculitis: a target trial emulation study.
2/2022	Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis.
1/2022	Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System.
1/2022	Expert Perspective: Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
12/2021	Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study.
11/2021	Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis.
1/2021	ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry.
1/2020	Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.
1/2020	All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type.
1/2020	Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John H Stone Research Topics

Disease

61	Immunoglobulin G4-Related Disease 04/2022 - 01/2012
39	Vasculitis (Vasculitides) 02/2022 - 01/2003
38	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022 - 07/2004
38	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 08/2003
26	Giant Cell Arteritis (Horton Disease) 04/2022 - 05/2002
13	Inflammation (Inflammations) 06/2022 - 04/2005
12	Fibrosis (Cirrhosis) 01/2022 - 05/2011
11	Microscopic Polyangiitis 01/2021 - 07/2004
6	COVID-19 01/2022 - 12/2020
6	Neoplasms (Cancer) 03/2019 - 05/2006
5	Rheumatoid Arthritis 06/2022 - 04/2005
5	Infections 12/2020 - 05/2007
4	Chronic Kidney Failure (Chronic Renal Failure) 10/2022 - 01/2018
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 06/2011
4	Hemorrhage 11/2019 - 07/2010
4	Membranous Glomerulonephritis (Membranous Nephropathy) 05/2019 - 01/2012
4	Glomerulonephritis 10/2018 - 01/2012
4	Aortitis 10/2017 - 10/2009
3	Sialadenitis 04/2022 - 02/2010
3	Stroke (Strokes) 12/2021 - 04/2011
3	Myocardial Infarction 12/2021 - 04/2011
3	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 07/2004
3	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2021 - 10/2004
3	Body Weight (Weight, Body) 12/2020 - 05/2007
3	Fatigue 01/2019 - 06/2008
3	Eosinophilia 07/2015 - 01/2014
3	Chronic Disease (Chronic Diseases) 02/2015 - 06/2007
2	Weight Gain 04/2022 - 05/2008
2	Asthma (Bronchial Asthma) 01/2022 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 04/2012
2	Hypersensitivity (Allergy) 01/2022 - 01/2014
2	Systemic Scleroderma (Systemic Sclerosis) 01/2022 - 01/2020
2	Shock 01/2022 - 01/2022
2	Macrophage Activation Syndrome 01/2022 - 01/2022
2	Aneurysm (Aneurysms) 01/2022 - 01/2022
2	Retroperitoneal Fibrosis 11/2021 - 10/2018
2	Venous Thromboembolism 11/2019 - 01/2017
2	Interstitial Nephritis (Tubulointerstitial Nephritis) 05/2019 - 10/2015
2	Lymphadenopathy 01/2019 - 05/2018
2	Atherosclerosis 01/2018 - 03/2010
2	Dacryocystitis (Dacryoadenitis) 02/2017 - 12/2015
2	Phlebitis 09/2016 - 01/2014
2	Long Term Adverse Effects 10/2015 - 01/2013
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 07/2015 - 01/2012

Drug/Important Bio-Agent (IBA)

49	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022 - 07/2004
45	Immunoglobulin G (IgG)IBA 04/2022 - 02/2010
39	Rituximab (Mabthera)FDA Link 01/2022 - 01/2005
29	GlucocorticoidsIBA 06/2022 - 05/2007
18	tocilizumab (atlizumab)FDA Link 04/2022 - 01/2013
15	Etanercept (Enbrel)FDA Link 12/2016 - 08/2003
14	Biomarkers (Surrogate Marker)IBA 02/2022 - 06/2011
14	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 05/2005
10	AutoantibodiesIBA 01/2022 - 04/2005
10	Myeloblastin (Proteinase 3)IBA 01/2022 - 04/2011
8	Prednisone (Sone)FDA LinkGeneric 01/2022 - 01/2013
7	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 05/2002
7	AntibodiesIBA 01/2020 - 05/2007
6	AutoantigensIBA 01/2022 - 01/2006
6	CytokinesIBA 01/2022 - 01/2013
6	Azathioprine (Imuran)FDA LinkGeneric 11/2019 - 05/2005
6	Immunoglobulins (Immunoglobulin)IBA 10/2017 - 01/2012
5	Immunoglobulin E (IgE)IBA 01/2022 - 01/2014
5	AntigensIBA 11/2021 - 01/2012
5	SteroidsIBA 01/2021 - 01/2012
5	Peroxidase (Myeloperoxidase)IBA 01/2020 - 04/2011
4	Interleukin-6 (Interleukin 6)IBA 10/2021 - 01/2013
4	EnzymesIBA 01/2020 - 11/2007
4	InterleukinsIBA 05/2017 - 01/2013
4	Methotrexate (Mexate)FDA LinkGeneric 10/2015 - 05/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2011 - 01/2003
3	Indicators and Reagents (Reagents)IBA 04/2022 - 12/2015
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2004
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 01/2013
3	Granzymes (Granzyme)IBA 01/2018 - 01/2016
3	Infliximab (Remicade)FDA Link 06/2011 - 05/2007
2	C-Reactive ProteinIBA 06/2022 - 11/2021
2	Biological ProductsIBA 01/2022 - 01/2017
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2022
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 11/2021 - 01/2017
2	Immunologic Factors (Immunomodulators)IBA 10/2021 - 01/2013
2	Pharmaceutical PreparationsIBA 01/2021 - 04/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 04/2016
2	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2013
2	ImmunosorbentsIBA 01/2020 - 11/2007
2	ChemokinesIBA 01/2020 - 12/2018
2	Galectin 3 (LGALS3)IBA 01/2020 - 01/2019
2	CollagenIBA 01/2020 - 12/2015
2	TinIBA 05/2019 - 10/2015
2	Phospholipase A2 ReceptorsIBA 05/2019 - 01/2012
2	Retinaldehyde (Retinal)IBA 01/2018 - 04/2016
2	interleukin-6 receptor alphaIBA 01/2017 - 01/2017
2	Prostaglandins AIBA 06/2015 - 06/2008
2	CreatinineIBA 04/2015 - 12/2005

Therapy/Procedure

37	Therapeutics 01/2022 - 01/2002
7	Remission Induction 01/2017 - 01/2005
3	Artificial Respiration (Mechanical Ventilation) 10/2021 - 10/2018
3	Aftercare (After-Treatment) 01/2018 - 12/2011
2	Kidney Transplantation 12/2021 - 01/2018
2	Immunomodulation 01/2021 - 06/2011